Clinuvel Pharmaceuticals Ltd. earnings per share and revenue

CLVLF earnings per share for the last semiannual are 0.33 USD whereas the estimation was 0.29 USD which accounts for 12.13% surprise. Company revenue for the same period amounts to 37.26 M USD despite the estimated figure of 36.59 M USD. Estimated earnings per share for the next semiannual are 0.13 USD, and revenue is expected to reach 21.47 M USD. Also watch annual changes over time to get a bigger picture of CLVLF earnings per share and revenue dynamics.